Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species

Toxicology and Applied Pharmacology
P I EachoS L White

Abstract

Previous work in this laboratory indicated that compound LY171883, a tetrazole-substituted alkoxyacetophenone with leukotriene D4 antagonist activity, caused dose-related hepatomegaly in rodents without other histological evidence of liver toxicity. In the present studies, administration of LY171883 at dietary concentrations of 0.25 or 0.50% to rats for 2 weeks increased peroxisomal beta-oxidation, catalase activity, and peroxisome volume fraction in the liver. The effects were dose-related and corresponded with increases in liver weight. Dietary concentrations of 0.05 and 0.1% LY171883 did not significantly alter peroxisome morphology, enzyme activity, or liver weight. Serum triglycerides were lowered equivalently by all four dietary concentrations of LY171883, indicating that the hypotriglyceridemia was dissociated from induction of peroxisomal beta-oxidation. The hepatic effects in rats reversed within 16 days after discontinuing treatment with LY171883. Liver weight and peroxisomal enzyme activities were increased in mice by LY171883 in a manner comparable to that observed in rats, whereas hamsters were less responsive. In guinea pigs there was a minor increase in beta-oxidation at a toxic dose of LY171883, but no change in...Continue Reading

Citations

Feb 4, 1992·Biochemical Pharmacology·S Green
Dec 1, 1995·Mutation Research·S Green
Mar 1, 1993·Mutation Research·M A JacksonM D Waters
Nov 1, 1992·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R J PriceB G Lake
Nov 1, 1993·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P BentleyH J Wiegand
Jan 1, 1990·Toxicology in Vitro : an International Journal Published in Association with BIBRA·F BieriP Bentley
Feb 1, 1994·Journal of Pharmacological and Toxicological Methods·P S Foxworthy, P I Eacho
May 26, 1999·Pharmacology & Therapeutics·S C Hasmall, R A Roberts
Dec 27, 1996·Annals of the New York Academy of Sciences·R A Roberts
Sep 30, 1999·Environmental Health Perspectives·J Youssef, M Badr
Jun 1, 1996·Critical Reviews in Toxicology·W W HuberR Schulte-Hermann
Dec 27, 1996·Annals of the New York Academy of Sciences·G M Williams, C Perrone
Dec 27, 1996·Annals of the New York Academy of Sciences·G G Gibson
Dec 27, 1996·Annals of the New York Academy of Sciences·P I EachoD J Noonan
Jun 1, 1988·Regulatory Toxicology and Pharmacology : RTP·W T Stott
Oct 1, 1992·Toxicology and Applied Pharmacology·S J GrossmanA G Zacchei
Feb 1, 1997·Regulatory Toxicology and Pharmacology : RTP·K T Bogen, L S Gold
Dec 28, 2004·Ageing Research Reviews·Jihan A Youssef, Mostafa Z Badr
Nov 1, 1991·Human & Experimental Toxicology·S Green
Mar 17, 2004·The Journal of Toxicological Sciences·Tetsuya Suga
Jul 2, 1999·Regulatory Toxicology and Pharmacology : RTP·J DoullM van Gemert
Apr 17, 1991·Biochimica Et Biophysica Acta·J YamadaT Suga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.